* participation in any other clinical trial of an experimental treatment and prevention for covid-19 * prior hospitalization for covid-19 * treatment with other agents with actual or possible direct antiviral activity against sars-cov-2 or administration of any sars-cov-2 (or covid-19) vaccine * requiring oxygen supplementation note: other protocol defined inclusion/exclusion criteria may apply.

* participation in any other clinical trial of an experimental treatment and prevention for covid-19 * prior hospitalization for covid-19 * treatment with other agents with actual or possible direct antiviral activity against sars-cov-2 or administration of any sars-cov-2 (or covid-19) vaccine * requiring oxygen supplementation note: other protocol defined inclusion/exclusion criteria may apply.

- participation in any other clinical trial of an experimental treatment and prevention for covid-19 - prior hospitalization for covid-19 - treatment with other agents with actual or possible direct antiviral activity against sars-cov-2 or administration of any sars-cov-2 (or covid-19) vaccine - requiring oxygen supplementation note: other protocol defined inclusion/exclusion criteria may apply.

- participation in any other clinical trial of an experimental treatment and prevention for covid-19 - prior hospitalization for covid-19 - treatment with other agents with actual or possible direct antiviral activity against sars-cov-2 or administration of any sars-cov-2 (or covid-19) vaccine - requiring oxygen supplementation note: other protocol defined inclusion/exclusion criteria may apply.

- participation in any other clinical trial of an experimental treatment and prevention for covid-19 - prior hospitalization for covid-19 - treatment with other agents with actual or possible direct antiviral activity against sars-cov-2 - requiring oxygen supplementation note: other protocol defined inclusion/exclusion criteria may apply.

- participation in any other clinical trial of an experimental treatment and prevention for covid-19 - prior hospitalization for covid-19 - treatment with other agents with actual or possible direct antiviral activity against sars-cov-2 - requiring oxygen supplementation note: other protocol defined inclusion/exclusion criteria may apply.

- participation in any other clinical trial of an experimental treatment and prevention for covid-19 - prior hospitalization for covid-19 - treatment with other agents with actual or possible direct antiviral activity against sars-cov-2 - use of hydroxychloroquine or chloroquine ≤ 7 days prior to screening - requiring oxygen supplementation note: other protocol defined inclusion/exclusion criteria may apply.

- participation in any other clinical trial of an experimental treatment and prevention for covid-19 - prior hospitalization for covid-19 - treatment with other agents with actual or possible direct antiviral activity against sars-cov-2 - use of hydroxychloroquine or chloroquine ≤ 7 days prior to screening - requiring oxygen supplementation note: other protocol defined inclusion/exclusion criteria may apply.